First 90 Days: Editas Medicine’s Gilmore O’Neill

Welcome to First 90 Days, a series dedicated to examining how pharma executives are planning for success in their new role. Today, we’re looking at Editas Medicine’s CEO, Gilmore O’Neill, who stepped into the role at the beginning of June to take the gene editing company to the next level in its biotech journey. Editas … Read more

First 90 Days: Janssen Immunology’s David Jimenez

Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. Staying at one company for decades isn’t for everyone. But during his 22-plus-year career at Johnson & Johnson, David Jimenez has always stayed on his toes — moving between different business units on four different continents in … Read more

First 90 Days: Syneos Health’s Michelle Keefe

Listen to the article 9 min This audio is auto-generated. Please let us know if you have feedback. Welcome to First 90 Days, a series dedicated to examining how pharma executives are planning for success in their new role. Today, we’re featuring a conversation with Michelle Keefe, Syneos Health’s new CEO, who approaches the role … Read more